Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition

C Allison Stewart,Lauren Averett Byers

DOI: https://doi.org/10.1016/j.ccell.2015.06.011

IF: 50.3

2015-07-13

Cancer Cell

Abstract:In this issue of Cancer Cell, Mohammad et al. describe LSD1, a histone demethylase, as a therapeutic target in SCLC with a unique epigenetic signature to predict drug sensitivity. Inhibition of LSD1 reduces cell proliferation and stem cell maintenance while promoting cell differentiation and reducing tumor growth in preclinical models.